EUROFINS SCIENTIFIC

Eurofins Scientific shares climb 2.4% amid strong Q2 earnings and senior staff share purchases, trading at €84.32 with a €14.2 B market cap.

Eurofins Scientific sees steady growth and strategic expansion, with 3‑4% revenue rise and unchanged 2026 profit targets, positioning it as a key player in lab‑services.

Eurofins Scientific’s March trading shows a slight uptick amid a cautious earnings report, highlighting fragile support, slow growth targets, and uncertainty over future integration.

Eurofins Scientific shares close up 0.87% amid share‑repurchase confidence, trading volume 18.8 M euros, and steady growth in a volatile market.